No link seen between COVID-19 and aspirin or ibuprofen


By Reuters Staff

(Reuters) - A large new study found no indication that use of non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin or ibuprofen increases people's vulnerability to infection by the new coronavirus.

Because early reports had suggested such a link, researchers used the COVID Symptom Study smartphone app to query more than 2.7 million individuals in the United States, the UK and Sweden about their use of aspirin and other NSAIDs, as well as about virus symptoms, COVID-19 testing, and healthcare seeking behavior.

Close to 9,000 participants reported a positive COVID-19 test during the study, according to a report posted on medRxiv in advance of peer review.

After accounting for individuals' lifestyle factors, other illnesses, and symptoms, regular use of NSAIDs was not associated with a higher risk of becoming infected with the coronavirus.

"There have been lingering concerns" that commonly used NSAIDs "could increase the risk of COVID infection or worsen the disease course among those who acquire the infection," coauthor Dr. Andrew Chan of the Massachusetts General Hospital in Boston told Reuters.

"Our study shows that there is no such an association and initial concerns were probably due to the fact that individuals with other risk factors for COVID or symptoms of COVID were more likely to take NSAIDs, rather than a cause and effect relationship," he said.

SOURCE: medRxiv, online May 2, 2021.

Related Articles

Reduced kidney function tied to increased dementia risk

By Megan Brooks NEW YORK (Reuters Health) - Older adults with reduced kidney function may be an increased risk of developing dementia, according to a large population-based study from Sweden. "Even a Read More »

Novavax vaccine shows 43% efficacy against South African variant, study finds

By Julie Steenhuysen CHICAGO (Reuters) - Novavax Inc's COVID-19 vaccine had efficacy of 43% against infections caused by the South African variant in a group that included people with and without HIV, Read More »

Moderna booster increases antibodies against COVID-19 variants, early data shows

By Carl O'Donnell (Reuters) - Moderna Inc said on Wednesday early human trial data shows that a third dose of either its current COVID-19 shot or an experimental new vaccine candidate increases Read More »

© 2021 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information